Abstract

Disease-Modifying Antirheumatic Drugs (Dmards): Revolutionizing Rheumatic Disease Management

Author(s): Sandra Deson*

Disease-Modifying Antirheumatic Drugs (DMARDs) have transformed the landscape of rheumatic disease treatment, particularly for conditions like rheumatoid arthritis (RA), psoriatic arthritis (PsA), and systemic lupus erythematosus (SLE). These medications do not merely alleviate symptoms; they alter the disease's course by targeting underlying pathological mechanisms, thus preventing joint damage and preserving function. This article explores the types of DMARDs, their mechanisms of action, clinical applications, and the impact they have had on the management of rheumatic diseases.